Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
300 participants
OBSERVATIONAL
2016-03-07
2030-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Long-term Outcome of DBS Versus Botulinum Toxin Treatment in Cervical Dystonia
NCT04432285
Study to Evaluate Safety, Efficacy of Botulinum Toxin Type A in Patients With Cervical Dystonia
NCT00564681
Phase IV-Cervical Dystonia-INTEREST IN CD2
NCT01753349
Physiotherapy and Botox for Cervical Dystonia: Impact of Sensory Tricks and Brain Imaging Insights
NCT06881147
Efficacy and Safety of Two Different Botulinum Toxin Type A Treatments for Moderate to Severe Cervical Dystonia
NCT00432341
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Subjects' improvement in disease symptoms and overall Quality of life will be assessed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Deep Brain Stimulation (DBS)
Subjects receiving Deep Brain Stimulation (DBS) for the treatment of their dystonia symptoms will be offered participation in this registry.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* IC2. At least 7 years old. Parent or guardian consent is required in patients who are younger than 18 years at the time of consent.
Exclusion Criteria
7 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Boston Scientific Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Natalie Bloom Lyons
Role: STUDY_DIRECTOR
Boston Scientific Neuromodulation Corporation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AZ Sint-Lucas
Ghent, , Belgium
UZ Gasthuisberg
Leuven, , Belgium
Queen Elizabeth II Health Sciences Center
Halifax, , Canada
University Berlin, Charite Virchow Standort, Wedding
Berlin, , Germany
Uniklinik Köln
Cologne, , Germany
Universitaetsklinikum Dusseldorf
Düsseldorf, , Germany
Universitaetsklinikum Freiburg
Freiburg im Breisgau, , Germany
Universitaetsklinik Eppendorf
Hamburg, , Germany
St. Barbara-Klinik Hamm-Heessen
Hamm, , Germany
Medizinische Hochschule Hannover MHH
Hanover, , Germany
Universitatsklinikum Campus Kiel
Kiel, , Germany
Johannes Gutenberg Universitaet Mainz
Mainz, , Germany
Universitaetsklinikum Giessen und Marburg GmbH
Marburg, , Germany
Evangelisches Krankenhaus Oldenburg
Oldenburg, , Germany
Universitaetsklinikum Wuerzburg
Würzburg, , Germany
Medical School of University PECS
Pécs, , Hungary
Hadassah Hebrew University Medical Center
Jerusalem, , Israel
Azienda Ospedaliero-Universitaria di Ferrara
Ferrara, , Italy
Ospedale Dell Angelo
Mestre, , Italy
Policlinico Universitario Agostino Gemelli
Rome, , Italy
Osp. S. Maria Della Misericordia
Udine, , Italy
Haga Ziekenhuis locatie Leyweg
The Hague, , Netherlands
10 Military Clinical Hospital Bydgoszcz
Bydgoszcz, , Poland
Wojewodzki Szpital Dzieciecy Jozefa Brudzinskiego (Childrens Hospital Bydgoszcz)
Bydgoszcz, , Poland
Podmiot Leczniczy Copernicus Sp. z o.o.
Gdansk, , Poland
Centrum Onkologii - Instytut im. Marii Sklodowskiej-Curie
Warsaw, , Poland
National Scientific Center of Neurosurgery N.N. Burdenko
Moscow, , Russia
St. Mary's Hospital Incheon
Incheon, , South Korea
Hospital Clinic de Barcelona
Barcelona, , Spain
University Hospital Virgen Arrixaca
El Palmar, , Spain
Centro Especial Ramon y Cajal
Madrid, , Spain
Hospital General De Asturias
Oviedo, , Spain
Southmead Hospital Bristol
Bristol, , United Kingdom
Queen Elizabeth University Hospital
Glasgow, , United Kingdom
Charing Cross Hospital
London, , United Kingdom
Royal Victoria Infirmary
Newcastle upon Tyne, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A4012
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.